Early Access — free while we kick the tires
EdgarHawk

Todd C Brady

President and CEO

Director Officer

Latest: President and CEO buying · June 2026

1 filing analyzed · 1 company · Latest 2026-06-05

Companies

Company Buys Sells Direction
Aldeyra Therapeutics, Inc. ALDX 1 0 Net buying

Activity

June 2026
medium
Buy
250,000 shares
$418,450
Significance 5/10

CEO Todd C Brady bought 250,000 shares of ALDX at $1.67 on 2026-06-03, expanding stake to 1.72M shares; stock down -72.3% from 52-week high.

Todd C Brady, President and CEO, purchased 250,000 shares at $1.67 for a total value of $418,450.00, increasing his holdings from 1.47M to 1.72M shares. The stock currently trades at $1.71, down -72.3% from its 52-week high of $6.18, and has declined -58.6% over the past 90 days. The company reported a net loss of $-3.5M over its most recent full fiscal year and remains unprofitable. Brady's prior trade history at ALDX consists of two sells (2024-03-12 and 2024-03-11), neither of which were well-timed at the 90-day horizon, as the stock rose after both sales. This open-market purchase by the CEO occurs against a backdrop of significant stock-price erosion and persistent losses, warranting monitoring of whether additional insider activity or operational developments follow.

Related insiders

Create a free account

Build watchlists, get email alerts on the tickers you follow, and read the full AI analysis on every insider filing.

Sign up — free during early access